| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mast Cells | 5 | 2018 | 225 | 1.960 |
Why?
|
| Platelet Activating Factor | 3 | 2017 | 57 | 1.130 |
Why?
|
| Immunity, Innate | 3 | 2019 | 700 | 0.940 |
Why?
|
| Drug Repositioning | 1 | 2019 | 53 | 0.640 |
Why?
|
| Catalase | 1 | 2018 | 75 | 0.620 |
Why?
|
| Extracellular Traps | 1 | 2018 | 24 | 0.610 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 151 | 0.600 |
Why?
|
| Valproic Acid | 1 | 2019 | 274 | 0.580 |
Why?
|
| Tolonium Chloride | 1 | 2017 | 3 | 0.570 |
Why?
|
| DNA Damage | 6 | 2015 | 1982 | 0.550 |
Why?
|
| Histocytochemistry | 1 | 2017 | 191 | 0.550 |
Why?
|
| Antigens, Nuclear | 2 | 2013 | 126 | 0.520 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2018 | 485 | 0.440 |
Why?
|
| DNA End-Joining Repair | 2 | 2013 | 92 | 0.440 |
Why?
|
| Radioimmunotherapy | 5 | 2024 | 128 | 0.420 |
Why?
|
| DNA Ligases | 4 | 2013 | 67 | 0.410 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 1082 | 0.400 |
Why?
|
| Epigenesis, Genetic | 2 | 2019 | 1443 | 0.400 |
Why?
|
| Ultraviolet Rays | 2 | 2011 | 588 | 0.390 |
Why?
|
| B-Lymphocytes | 3 | 2013 | 1424 | 0.360 |
Why?
|
| Nanoparticles | 3 | 2024 | 585 | 0.340 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 301 | 0.330 |
Why?
|
| Homeostasis | 2 | 2013 | 926 | 0.320 |
Why?
|
| Mice | 23 | 2024 | 35592 | 0.320 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2024 | 1655 | 0.320 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 3 | 2024 | 1738 | 0.300 |
Why?
|
| Animals | 29 | 2024 | 62021 | 0.300 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2008 | 174 | 0.270 |
Why?
|
| Cellular Senescence | 5 | 2013 | 389 | 0.270 |
Why?
|
| Genes, p53 | 1 | 2011 | 1140 | 0.270 |
Why?
|
| Genes, Lethal | 1 | 2006 | 131 | 0.260 |
Why?
|
| DNA-Binding Proteins | 4 | 2013 | 5001 | 0.260 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2024 | 255 | 0.260 |
Why?
|
| Immunotherapy | 7 | 2023 | 3555 | 0.250 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2017 | 537 | 0.240 |
Why?
|
| Gene Targeting | 1 | 2006 | 314 | 0.240 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2004 | 12 | 0.240 |
Why?
|
| Lung Neoplasms | 6 | 2024 | 12021 | 0.230 |
Why?
|
| Lymphoma, B-Cell | 1 | 2011 | 929 | 0.230 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2004 | 79 | 0.220 |
Why?
|
| Environmental Pollutants | 1 | 2004 | 86 | 0.220 |
Why?
|
| Tumor Microenvironment | 3 | 2024 | 3031 | 0.220 |
Why?
|
| TNF Receptor-Associated Factor 3 | 2 | 2013 | 22 | 0.220 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2023 | 39 | 0.210 |
Why?
|
| Apoptosis | 5 | 2019 | 7753 | 0.210 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 744 | 0.210 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2002 | 36 | 0.210 |
Why?
|
| Activins | 1 | 2022 | 94 | 0.210 |
Why?
|
| Biological Products | 2 | 2024 | 319 | 0.210 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 553 | 0.210 |
Why?
|
| Chick Embryo | 1 | 2002 | 220 | 0.200 |
Why?
|
| Luteinizing Hormone | 1 | 2002 | 165 | 0.200 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2002 | 224 | 0.200 |
Why?
|
| Caspases | 1 | 2004 | 679 | 0.200 |
Why?
|
| Cell Line | 4 | 2018 | 5339 | 0.190 |
Why?
|
| Immunotherapy, Adoptive | 4 | 2024 | 1840 | 0.190 |
Why?
|
| Cell- and Tissue-Based Therapy | 2 | 2023 | 381 | 0.190 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2022 | 247 | 0.190 |
Why?
|
| Cell Proliferation | 5 | 2019 | 7242 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell | 3 | 2023 | 1135 | 0.190 |
Why?
|
| Interleukin-2 | 1 | 2024 | 889 | 0.180 |
Why?
|
| Cell Cycle | 3 | 2019 | 2137 | 0.180 |
Why?
|
| Adenocarcinoma | 2 | 2022 | 7884 | 0.180 |
Why?
|
| Neoplasms | 4 | 2021 | 15905 | 0.170 |
Why?
|
| Tumor Escape | 1 | 2021 | 247 | 0.170 |
Why?
|
| Mice, Knockout | 3 | 2017 | 5725 | 0.170 |
Why?
|
| DNA Repair | 1 | 2008 | 1910 | 0.170 |
Why?
|
| RNA Interference | 2 | 2019 | 1386 | 0.170 |
Why?
|
| Lymphoma | 1 | 2008 | 1517 | 0.160 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2013 | 3655 | 0.160 |
Why?
|
| Tryptases | 1 | 2018 | 47 | 0.150 |
Why?
|
| Blood Cells | 1 | 2018 | 129 | 0.150 |
Why?
|
| Acetylation | 2 | 2017 | 515 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 3700 | 0.150 |
Why?
|
| Cells, Cultured | 3 | 2015 | 5690 | 0.150 |
Why?
|
| Antigens, CD | 1 | 2022 | 1418 | 0.140 |
Why?
|
| Eosine Yellowish-(YS) | 1 | 2017 | 31 | 0.140 |
Why?
|
| Hematoxylin | 1 | 2017 | 33 | 0.140 |
Why?
|
| Receptors, CXCR4 | 2 | 2017 | 278 | 0.140 |
Why?
|
| Radiation Dosage | 1 | 2021 | 1043 | 0.140 |
Why?
|
| Histone Deacetylases | 1 | 2019 | 364 | 0.140 |
Why?
|
| Ku Autoantigen | 2 | 2013 | 82 | 0.140 |
Why?
|
| Radiotherapy | 2 | 2021 | 1858 | 0.140 |
Why?
|
| DNA Ligase ATP | 4 | 2013 | 53 | 0.130 |
Why?
|
| Histone Code | 1 | 2017 | 86 | 0.130 |
Why?
|
| Recombination, Genetic | 2 | 2009 | 665 | 0.130 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2009 | 327 | 0.130 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 4887 | 0.130 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2015 | 83 | 0.130 |
Why?
|
| Cell Line, Tumor | 5 | 2024 | 14836 | 0.130 |
Why?
|
| Melanoma | 2 | 2023 | 5595 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 617 | 0.120 |
Why?
|
| Photosensitizing Agents | 1 | 2015 | 81 | 0.120 |
Why?
|
| Hematopoiesis | 1 | 2018 | 604 | 0.120 |
Why?
|
| Photochemotherapy | 1 | 2015 | 116 | 0.120 |
Why?
|
| Proton Therapy | 1 | 2024 | 1635 | 0.110 |
Why?
|
| Humans | 21 | 2024 | 270457 | 0.110 |
Why?
|
| Inducible T-Cell Co-Stimulator Protein | 1 | 2013 | 78 | 0.110 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2015 | 272 | 0.110 |
Why?
|
| Immunity, Humoral | 1 | 2013 | 88 | 0.110 |
Why?
|
| Germinal Center | 1 | 2013 | 167 | 0.110 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2015 | 322 | 0.110 |
Why?
|
| Cell Differentiation | 2 | 2022 | 4121 | 0.100 |
Why?
|
| Endopeptidases | 1 | 2013 | 231 | 0.100 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 160 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2018 | 613 | 0.090 |
Why?
|
| STAT3 Transcription Factor | 1 | 2018 | 1135 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2013 | 591 | 0.090 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 445 | 0.090 |
Why?
|
| VDJ Exons | 1 | 2009 | 7 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2013 | 579 | 0.090 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2009 | 67 | 0.090 |
Why?
|
| Antineoplastic Agents | 2 | 2022 | 14623 | 0.090 |
Why?
|
| Colon | 1 | 2013 | 680 | 0.080 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2013 | 714 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2015 | 4947 | 0.080 |
Why?
|
| beta Catenin | 1 | 2013 | 688 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2013 | 1051 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2013 | 842 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2018 | 7093 | 0.080 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 3213 | 0.080 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 1 | 2008 | 47 | 0.080 |
Why?
|
| Interleukin-10 | 1 | 2011 | 484 | 0.080 |
Why?
|
| Immune Tolerance | 1 | 2010 | 423 | 0.080 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2008 | 52 | 0.080 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2009 | 218 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 1586 | 0.070 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2007 | 438 | 0.070 |
Why?
|
| Osteosarcoma | 1 | 2015 | 948 | 0.070 |
Why?
|
| Radiation Tolerance | 1 | 2010 | 637 | 0.070 |
Why?
|
| Carcinogenesis | 1 | 2013 | 1035 | 0.070 |
Why?
|
| Sister Chromatid Exchange | 1 | 2006 | 45 | 0.070 |
Why?
|
| Restriction Mapping | 1 | 2006 | 330 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2013 | 1872 | 0.070 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2006 | 117 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2021 | 3944 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2013 | 1562 | 0.070 |
Why?
|
| Blotting, Southern | 1 | 2006 | 451 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2024 | 7371 | 0.060 |
Why?
|
| Electroporation | 1 | 2006 | 127 | 0.060 |
Why?
|
| Xenopus Proteins | 1 | 2006 | 193 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5566 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2010 | 1900 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 655 | 0.060 |
Why?
|
| Avian Proteins | 1 | 2004 | 25 | 0.060 |
Why?
|
| Salmonella typhimurium | 1 | 2004 | 73 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2021 | 4814 | 0.060 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 2004 | 83 | 0.060 |
Why?
|
| c-Mer Tyrosine Kinase | 1 | 2024 | 28 | 0.060 |
Why?
|
| Fibronectins | 1 | 2004 | 206 | 0.060 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2004 | 130 | 0.060 |
Why?
|
| Caspase 9 | 1 | 2004 | 187 | 0.060 |
Why?
|
| Proto-Oncogenes | 1 | 2024 | 208 | 0.060 |
Why?
|
| Chickens | 1 | 2004 | 783 | 0.060 |
Why?
|
| Oxidoreductases | 1 | 2004 | 168 | 0.060 |
Why?
|
| Homozygote | 1 | 2006 | 771 | 0.060 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 2031 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2007 | 3592 | 0.060 |
Why?
|
| Caspase 3 | 1 | 2004 | 474 | 0.050 |
Why?
|
| Female | 10 | 2024 | 148644 | 0.050 |
Why?
|
| STAT6 Transcription Factor | 1 | 2023 | 68 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2006 | 1685 | 0.050 |
Why?
|
| HLA-A2 Antigen | 1 | 2023 | 172 | 0.050 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2024 | 366 | 0.050 |
Why?
|
| Exons | 1 | 2006 | 1382 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 2664 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 1497 | 0.050 |
Why?
|
| Cytokines | 1 | 2011 | 2824 | 0.050 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2024 | 594 | 0.050 |
Why?
|
| Photons | 1 | 2024 | 536 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2009 | 2117 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2004 | 1814 | 0.050 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 314 | 0.050 |
Why?
|
| Immunologic Memory | 1 | 2022 | 380 | 0.040 |
Why?
|
| Mutation | 4 | 2010 | 15908 | 0.040 |
Why?
|
| Protons | 1 | 2023 | 482 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 1185 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2002 | 469 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 1121 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2021 | 9041 | 0.040 |
Why?
|
| Antigens, CD19 | 1 | 2023 | 584 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 3471 | 0.040 |
Why?
|
| Stem Cells | 1 | 2006 | 1215 | 0.040 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2020 | 125 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 3607 | 0.040 |
Why?
|
| Cell-Free Nucleic Acids | 1 | 2020 | 232 | 0.040 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2018 | 96 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2024 | 33708 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2022 | 1109 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2013 | 1270 | 0.030 |
Why?
|
| Macrophages | 1 | 2023 | 1351 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2022 | 2031 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2018 | 273 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 5071 | 0.030 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 1094 | 0.030 |
Why?
|
| Insulin | 2 | 2013 | 1487 | 0.030 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 4222 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2013 | 1656 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2018 | 696 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2004 | 6394 | 0.030 |
Why?
|
| Chromatography, Gas | 1 | 2013 | 39 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 2013 | 154 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2013 | 201 | 0.030 |
Why?
|
| Pregnancy | 1 | 2006 | 8101 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 809 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 1207 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 893 | 0.030 |
Why?
|
| Transcriptome | 1 | 2020 | 1954 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 4476 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 1371 | 0.020 |
Why?
|
| Proteolysis | 1 | 2013 | 377 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 3844 | 0.020 |
Why?
|
| Photosensitivity Disorders | 1 | 2010 | 22 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 1516 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 5309 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 1200 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 1111 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2009 | 185 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 905 | 0.020 |
Why?
|
| Glucose Intolerance | 1 | 2009 | 86 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 563 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1462 | 0.020 |
Why?
|
| Male | 4 | 2020 | 128105 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2009 | 236 | 0.020 |
Why?
|
| Time Factors | 1 | 2002 | 12991 | 0.020 |
Why?
|
| Intestines | 1 | 2013 | 724 | 0.020 |
Why?
|
| Bacteria | 1 | 2013 | 653 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2010 | 221 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2009 | 437 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 623 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 3045 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2009 | 501 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 7646 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 252 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2009 | 520 | 0.020 |
Why?
|
| Aged | 2 | 2023 | 73175 | 0.020 |
Why?
|
| Pancreas | 1 | 2009 | 744 | 0.020 |
Why?
|
| Cytogenetic Analysis | 1 | 2007 | 574 | 0.020 |
Why?
|
| Skin | 1 | 2010 | 1270 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2009 | 1272 | 0.010 |
Why?
|
| Immune Sera | 1 | 2004 | 145 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2009 | 1122 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 2004 | 110 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1542 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2004 | 470 | 0.010 |
Why?
|
| Rabbits | 1 | 2004 | 1047 | 0.010 |
Why?
|
| Histones | 1 | 2009 | 1513 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 2308 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 2255 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2015 | 9041 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 1641 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2004 | 1305 | 0.010 |
Why?
|
| Phenotype | 1 | 2009 | 6497 | 0.010 |
Why?
|
| Protein Binding | 1 | 2004 | 3486 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 81754 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 90100 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2009 | 12104 | 0.010 |
Why?
|